Company Overview and News
The SPDR Energy Select Sector, formed in late-1998, has more than $19Bn of assets under management, which makes it one of the most well established ETFs in the industry.
XLE VDE FENY KMI.WS XOM NOV SU VNGE EOG SQTI KMI.PRA KMI SLB SND KMR CVB KMRFZ SU
The S&P 500 is up over 3% in the first half of July and Nasdaq is at an all-time high, despite the ongoing tariff disputes with China. I believe the press has overblown the “trade war” story, but the overall market is waking up to the fact that the likely eventual outcome will be fewer tariffs and fairer trade in the end.
BP EC BBY GPRK WMT SU SU EQNR
This year, oil prices have been spiking and hitting prices which have not been seen since 2014. However, thanks to more recent news, the continuous rally finally seems to have come to a slow halt.
APA MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA SU SU
CALGARY (Reuters) - Syncrude Canada on Friday told buyers it would cut crude deliveries in August by about 35 percent after an outage last month at its oil sands site in northern Alberta, two market sources familiar with the matter said.
Occidental Petroleum Corporation’s (OXY - Free Report) Board of Directors announced the company’s regular quarterly dividend of 78 cents per share, which annually stands at $3.12. The figure reflects a 1.3% hike compared with the previous annual rate of $3.08 per share. Details of the Dividend Raise The quarterly dividend of 78 cents per share is payable Oct 15, 2018 to shareholders of record as of Sep 10, 2018.
APC OXY AEUA SU SU
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CNQ MEG TXCX MEGEF CEO SU SU
HollyFrontier Corporation (HFC - Free Report) recently inked a deal to acquire a private lubricants firm, Red Giant Oil Company. Founded in 1963, Iowa-based Red Giant Oil is one of the largest suppliers of locomotive engine oil in North America. Red Giant produces around 24 million gallons of diesel engine oil annually. The financial details of the acquisition have been kept under wraps. Subject to approvals and satisfactory closing conditions, the deal is set for closure in the third quarter of 2018.
DK HFC CVRR SU SU
One stock that might be an intriguing choice for investors right now is Suncor Energy Inc. (SU - Free Report) . This is because this security in the Oil and Gas - Integrated – Canadian space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.
CALGARY, July 10 (Reuters) - Executives at Canada's largest integrated oil and gas producers on Tuesday downplayed the severity of transportation bottlenecks to move oil in the near term, citing existing pipeline commitments and refining capabilities.
HSE ENB ENBBF CVE IMO CVE EBBNF ENB HUSKF IMO SU SU
Executives from the biggest oilsands companies in Canada say concerns about getting their products to market are starting to ease in the wake of the regulatory approval of Enbridge Inc.'s $9-billion Line 3 pipeline replacement project.
ENBBF CVE IMO ENB HUSKF IMO SU HSE ENB CNQ CVE EBBNF SU
NEW YORK (Reuters) - Oil prices rose on Tuesday on growing supply disruptions in Norway and Libya, but gains were pared after the United States said it would consider requests for waivers from Iranian oil sanctions.
11h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
13h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TSX:SU / Suncor Energy Inc. on message board site Silicon Investor.